<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR80">
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Han</surname>
    <given-names>Z</given-names>
   </name>
   <name>
    <surname>Harris</surname>
    <given-names>PK</given-names>
   </name>
   <name>
    <surname>Karmakar</surname>
    <given-names>P</given-names>
   </name>
   <name>
    <surname>Kim</surname>
    <given-names>T</given-names>
   </name>
   <name>
    <surname>Owusu</surname>
    <given-names>BY</given-names>
   </name>
   <name>
    <surname>Wildman</surname>
    <given-names>SA</given-names>
   </name>
   <name>
    <surname>Klampfer</surname>
    <given-names>L</given-names>
   </name>
   <name>
    <surname>Janetka</surname>
    <given-names>JW</given-names>
   </name>
  </person-group>
  <article-title>alpha-Ketobenzothiazole Serine Protease inhibitors of aberrant HGF/c-MET and MSP/RON Kinase pathway signaling in cancer</article-title>
  <source>ChemMedChem</source>
  <year>2016</year>
  <volume>11</volume>
  <fpage>585</fpage>
  <lpage>599</lpage>
  <pub-id pub-id-type="doi">10.1002/cmdc.201500600</pub-id>
  <?supplied-pmid 26889658?>
  <pub-id pub-id-type="pmid">26889658</pub-id>
 </element-citation>
</ref>
